(Q38219787)

31 August 2017

The re-emerging role of microbial natural products in antibiotic discovery (English)

1 reference

31 August 2017

0 references

1 reference

Olga Genilloud

1

0 references

publication date

13 June 2014

1 reference

31 August 2017

16

1 reference

based on heuristic

inferred from page(s)

published in

Antonie van Leeuwenhoek

1 reference

31 August 2017

106

1 reference

31 August 2017

1

1 reference

31 August 2017

173-188

1 reference

https://scigraph.springernature.com/pub.10.1007/s10482-014-0204-6

31 August 2017

0 references

cites work

Pyocyanin isolated from a marine microbial population: synergistic production between two distinct bacterial species and mode of action

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Recent application of metagenomic approaches toward the discovery of antimicrobials and other bioactive small molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Thoughts and facts about antibiotics: where we are now and where we are heading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Enhancement of antibiotic and secondary metabolite detection from filamentous fungi by growth on nutritional arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Coprophilous fungi: antibiotic discovery and functions in an underexplored arena of microbial defensive mutualism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Entomopathogenic bacteria as a source of secondary metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Big effects from small changes: possible ways to explore nature's chemical diversity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Secondary metabolic gene cluster silencing in Aspergillus nidulans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Fungal secondary metabolites - strategies to activate silent gene clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Improving known classes of antibiotics: an optimistic approach for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

The role of natural product chemistry in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Natural products--the future scaffolds for novel antibiotics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Antibiotics in the clinical pipeline in 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

New natural product biosynthetic chemistry discovered by genome mining

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

2-Alkyl-4-hydroxymethylfuran-3-carboxylic acids, antibiotic production inducers discovered by Streptomyces coelicolor genome mining

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Chemical perturbation of secondary metabolism demonstrates important links to primary metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Bacterial symbionts and natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Pestalone, a new antibiotic produced by a marine fungus in response to bacterial challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Antibiotic discovery in the twenty-first century: current trends and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Imaging mass spectrometry of natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Antibiotics for emerging pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Metagenome mining reveals polytheonamides as posttranslationally modified ribosomal peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

The impact of natural products upon modern drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Current challenges in the discovery of novel antibacterials from microbial natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Current approaches to exploit actinomycetes as a source of novel natural products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Coelomycin, a highly substituted 2,6-dioxo-pyrazine fungal metabolite antibacterial agent discovered by Staphylococcus aureus fitness test profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Heterologous expression of natural product biosynthetic gene clusters in Streptomyces coelicolor: from genome mining to manipulation of biosynthetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Genomics of secondary metabolite production by Pseudomonas spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

The genomisotopic approach: a systematic method to isolate products of orphan biosynthetic gene clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Iron and metal regulation in bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

A chemical epigenetics approach for engineering the in situ biosynthesis of a cryptic natural product from Aspergillus niger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

The role of absC, a novel regulatory gene for secondary metabolism, in zinc-dependent antibiotic production in Streptomyces coelicolor A3(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Antibacterial discovery in actinomycetes strains with mutations in RNA polymerase or ribosomal protein S12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Species-specific secondary metabolite production in marine actinomycetes of the genus Salinispora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Isolating "uncultivable" microorganisms in pure culture in a simulated natural environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Mining cyanobacterial genomes for genes encoding complex biosynthetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

A mass spectrometry-guided genome mining approach for natural product peptidogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

SMURF: Genomic mapping of fungal secondary metabolite clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Recent derivatives from smaller classes of fermentation-derived antibacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Developing new antibacterials through natural product research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Avenolide, a Streptomyces hormone controlling antibiotic production in Streptomyces avermitilis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

The evolving role of natural products in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Engineered Streptomyces avermitilis host for heterologous expression of biosynthetic gene cluster for secondary metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Identification of a bioactive 51-membered macrolide complex by activation of a silent polyketide synthase in Streptomyces ambofaciens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Platforms for antibiotic discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Uncultured microorganisms as a source of secondary metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Has the era of untreatable infections arrived?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Genomic basis for natural product biosynthetic diversity in the actinomycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Natural products as sources of new drugs over the 30 years from 1981 to 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Metabolomics methods for the synthetic biology of secondary metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Induced production of emericellamides A and B from the marine-derived fungus Emericella sp. in competing co-culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Mycolic acid-containing bacteria induce natural-product biosynthesis in Streptomyces species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Antisense-guided isolation and structure elucidation of pannomycin, a substituted cis-decalin from Geomyces pannorum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Drugs for bad bugs: confronting the challenges of antibacterial discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Myxococcus xanthus induces actinorhodin overproduction and aerial mycelium formation by Streptomyces coelicolor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Metabolites from symbiotic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Approaches to capturing and designing biologically active small molecules produced by uncultured microbes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

The Uncultured Microbial Majority

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Feast or famine: the global regulator DasR links nutrient stress to antibiotic production by Streptomyces

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Novel chemical space exploration via natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Production of microbial secondary metabolites: regulation by the carbon source.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Engineering fungal secondary metabolism: a roadmap to novel compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Natural products as catalysts for innovation: a pharmaceutical industry perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Meta-omic characterization of prokaryotic gene clusters for natural product biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Intimate bacterial-fungal interaction triggers biosynthesis of archetypal polyketides in Aspergillus nidulans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Histone deacetylase activity regulates chemical diversity in Aspergillus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Challenges of antibacterial discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Discovery of lucensimycins A and B from Streptomyces lucensis MA7349 using an antisense strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Screening strategies for discovery of antibacterial natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Growing unculturable bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

The regulation of the secondary metabolism of Streptomyces: new links and experimental advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Fidaxomicin: a novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Natural products version 2.0: connecting genes to molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Platensimycin is a selective FabF inhibitor with potent antibiotic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Capturing bacterial metabolic exchange using thin film desorption electrospray ionization-imaging mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

The impact of genomics on the exploitation of the myxobacterial secondary metabolome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Metagenomic approaches for exploiting uncultivated bacteria as a resource for novel biosynthetic enzymology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

An environmental bacterial taxon with a large and distinct metabolic repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Synthetic biological approaches to natural product biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Genomics-inspired discovery of natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

21 January 2018

Antibiotics: a new hope

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Desferrioxamine E produced by Streptomyces griseus stimulates growth and development of Streptomyces tanashiensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Strategies for the discovery of new natural products by genome mining

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Isolation, structure, and antibacterial activity of phaeosphenone from a Phaeosphaeria sp. discovered by antisense strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Diversity and evolution of secondary metabolism in the marine actinomycete genus Salinispora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Marine actinomycetes as an emerging resource for the drug development pipelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Chemical and Physical Modulation of Antibiotic Activity in Emericella Species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-014-0204-6

Closthioamide: An Unprecedented Polythioamide Antibiotic from the Strictly Anaerobic Bacterium Clostridium cellulolyticum

21 January 2018

1 reference

9 March 2024

https://opencitations.net/index/api/v1/citations/10.1002/ANIE.200906114

Identifiers

DOI

10.1007/S10482-014-0204-6

1 reference

PubMed ID

24923558

Dimensions Publication ID

31 August 2017

0 references

1 reference

PubMed ID

24923558